Amneal [AMRX] vs Zoetis [ZTS] Detailed Stock Comparison

Amneal

NASDAQ
Loading...

Zoetis

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Amneal wins in 7 metrics, Zoetis wins in 12 metrics, with 0 ties. Zoetis appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Amneal Zoetis Better
P/E Ratio (TTM) 1,036.00 25.16 Zoetis
Price-to-Book Ratio -29.23 13.06 Amneal
Debt-to-Equity Ratio -22.94 137.01 Amneal
PEG Ratio 4.14 1.44 Zoetis
EV/EBITDA 9.32 17.80 Amneal
Profit Margin (TTM) 0.12% 27.83% Zoetis
Operating Margin (TTM) 15.46% 40.20% Zoetis
EBITDA Margin (TTM) 15.46% 40.20% Zoetis
Return on Equity 106.73% 52.77% Amneal
Return on Assets (TTM) 6.85% 15.37% Zoetis
Free Cash Flow (TTM) $220.11M $2.30B Zoetis
Dividend Yield N/A 1.11% N/A
1-Year Return 20.07% -22.95% Amneal
Price-to-Sales Ratio (TTM) 1.14 6.91 Amneal
Enterprise Value $5.83B $70.26B Zoetis
EV/Revenue Ratio 2.04 7.49 Amneal
Gross Profit Margin (TTM) 39.51% 73.62% Zoetis
Revenue per Share (TTM) $9 $21 Zoetis
Earnings per Share (Diluted) $0.01 $5.82 Zoetis
Beta (Stock Volatility) 1.18 0.90 Zoetis
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Amneal vs Zoetis Stock Performance Analysis

Loading Price Chart...

Amneal
Zoetis
Amneal Stock Overview | Zoetis Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Amneal-3.11%-1.06%4.04%23.53%38.49%32.60%
Zoetis1.51%2.03%-3.94%-8.02%-8.26%-9.96%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Amneal20.07%425.00%99.81%-30.00%-30.00%-30.00%
Zoetis-22.95%-0.64%-11.49%242.10%372.17%372.17%

News Based Sentiment: Amneal vs Zoetis

Amneal

News based Sentiment: POSITIVE

Amneal Pharmaceuticals experienced a highly positive month, driven by strong stock performance, positive analyst revisions, strategic debt refinancing, and progress in its product pipeline. While insider selling warrants monitoring, the overall narrative points to a company on a solid growth trajectory.

View Amneal News Sentiment Analysis

Zoetis

News based Sentiment: MIXED

The month featured both positive developments – the CVMP opinion for Portela® and generally positive analyst estimates – alongside negative signals like stock decline, technical warnings, and mixed institutional activity. This creates a balanced, rather than decisively positive or negative, investment narrative.

View Zoetis News Sentiment Analysis

Performance & Financial Health Analysis: Amneal vs Zoetis

MetricAMRXZTS
Market Information
Market Cap i$3.25B$65.09B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i1,708,4203,169,830
90 Day Avg. Volume i1,696,7902,720,843
Last Close$9.97$167.10
52 Week Range$6.68 - $10.68$139.70 - $200.33
% from 52W High-6.60%-16.59%
All-Time High$24.48 (Aug 20, 2018)$249.27 (Dec 27, 2021)
% from All-Time High-59.27%-32.96%
Growth Metrics
Quarterly Revenue Growth0.03%0.04%
Quarterly Earnings Growth2.74%0.15%
Financial Health
Profit Margin (TTM) i0.00%0.28%
Operating Margin (TTM) i0.15%0.40%
Return on Equity (TTM) i1.07%0.53%
Debt to Equity (MRQ) i-22.94137.01
Cash & Liquidity
Book Value per Share (MRQ)$-0.36$11.21
Cash per Share (MRQ)$0.24$3.28
Operating Cash Flow (TTM) i$351.08M$2.93B
Levered Free Cash Flow (TTM) i$333.75M$2.29B
Dividends
Last 12-Month Dividend Yield iN/A1.11%
Last 12-Month Dividend iN/A$1.86

Valuation & Enterprise Metrics Analysis: Amneal vs Zoetis

MetricAMRXZTS
Price Ratios
P/E Ratio (TTM) i1,036.0025.16
Forward P/E i14.5923.09
PEG Ratio i4.141.44
Price to Sales (TTM) i1.146.91
Price to Book (MRQ) i-29.2313.06
Market Capitalization
Market Capitalization i$3.25B$65.09B
Enterprise Value i$5.83B$70.26B
Enterprise Value Metrics
Enterprise to Revenue i2.047.49
Enterprise to EBITDA i9.3217.80
Risk & Other Metrics
Beta i1.180.90
Book Value per Share (MRQ) i$-0.36$11.21

Financial Statements Comparison: Amneal vs Zoetis

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)AMRXZTS
Revenue/Sales i$695.42M$2.22B
Cost of Goods Sold i$439.53M$622.00M
Gross Profit i$255.89M$1.60B
Research & Development i$41.81M$157.00M
Operating Income (EBIT) i$100.92M$846.00M
EBITDA i$161.60M$991.00M
Pre-Tax Income i$37.49M$810.00M
Income Tax i$12.87M$179.00M
Net Income (Profit) i$24.62M$631.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)AMRXZTS
Cash & Equivalents i$59.19M$1.72B
Total Current Assets i$1.51B$5.88B
Total Current Liabilities i$1.08B$3.39B
Long-Term Debt i$2.24B$5.40B
Total Shareholders Equity i$-59.39M$4.66B
Retained Earnings i$-594.87M$12.38B
Property, Plant & Equipment i$522.75M$6.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)AMRXZTS
Operating Cash Flow i$-11.03M$567.00M
Capital Expenditures i$-13.60MN/A
Free Cash Flow i$-10.91M$438.00M
Debt Repayment i$-235.53MN/A
Common Stock Repurchase iN/A$-443.00M

Short Interest & Institutional Ownership Analysis

MetricAMRXZTS
Shares Short i5.05M9.19M
Short Ratio i3.323.71
Short % of Float i0.03%0.02%
Average Daily Volume (10 Day) i1,708,4203,169,830
Average Daily Volume (90 Day) i1,696,7902,720,843
Shares Outstanding i309.88M448.47M
Float Shares i168.76M442.31M
% Held by Insiders i0.46%0.00%
% Held by Institutions i0.46%0.99%

Dividend Analysis & Yield Comparison: Amneal vs Zoetis

MetricAMRXZTS
Last 12-Month Dividend iN/A$1.86
Last 12-Month Dividend Yield iN/A1.11%
3-Year Avg Annual Dividend iN/A$1.63
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$4.90
Ex-Dividend DateN/AApr 21, 2025